UNITY Biotechnology Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with Listing Requirements
I'm PortAI, I can summarize articles.
UNITY Biotechnology Inc. has received a notification from Nasdaq regarding non-compliance with listing requirements due to its stock closing below $1.00 for 30 consecutive business days and stockholders’ equity falling below $10 million. The company has submitted a compliance plan and applied to transfer to the Nasdaq Capital Market, with a deadline to resolve these issues by December 15, 2025. There is currently no immediate impact on its Nasdaq listing or stock trading.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments